Introduction : There is a growing need to evaluate the factors contributing to the increase in health expenditures, as well as the cost of medicines used in the treatment of Type 2 diabetes mell
Performances of HbA1c corresponding with dysglycaemia, and screen-detected diabetes among the participants without history of diabetes from ROC curve analysis.
